Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice

TerminatedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Breast Neoplasms
Trial Locations (19)

23007

Complejo Hospitalario Jaén, Jaén

28033

MD Anderson, Madrid

28040

Hospital Clínico San Carlos, Madrid

28041

Hospital 12 octubre, Madrid

28223

Hospital Quirón, Madrid

30008

Hospital Morales Meseguer, Murcia

30202

Hospital Santa Lucía, Cartagena

31008

Hospital Navarra, Pamplona

32005

Complejo Hospitalario Orense, Ourense

37007

Hospital Clínico Salamanca, Salamanca

43204

Hospital Universitario San Joan Reus, Reus

45071

Hospital Virgen Salud, Toledo

50009

Hospital Clínico Lozano Blesa, Zaragoza

09006

Hospital Universitario Burgos, Burgos

47005:

Hospital Clínico Valladolid, Valladolid

08035

Hospital Vall d´Hebron, Barcelona

06006

Hospital Infanta Cristina, Badajoz

06011

Capio Clideba, Badajoz

28007:

Hospital Gregorio Marañón, Madrid

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY